article thumbnail

David Liu receives Breakthrough Prize in Life Sciences

Broad Institute

Since their initial development, both base editing and prime editing have been used by thousands of laboratories around the world and have enabled the study and potential treatment of many genetic diseases. The Breakthrough Prize is one of the worlds most important science awards.

Science 144
article thumbnail

Simple test for flu could improve diagnosis and surveillance

Broad Institute

Appearing today in The Journal of Molecular Diagnostics , the results could help improve outbreak response and clinical care by bringing tests that are accurate, low-cost, and fast to doctors’ offices and labs across the US and in other countries. We’re excited to apply it to H5N1.” Paper cited Zhang YB, Arizti-Sanz J, et al.

Virus 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

FDA Law Blog: Biosimilars

Gibbs — For more than three decades, FDA has claimed that the Federal Food, Drug & Cosmetic (FD&C Act) gives the agency legal authority to regulate laboratory developed tests (LDTs) as medical devices (see our prior post here ). Gaulkin & Jeffrey N.

article thumbnail

Michael Trembley

Broad Institute

Scientist II Michael Trembley is a scientist II at the Precision Cardiology Laboratory (PCL) of the Broad Institute and Bayer, where his research is focused on discovering and validating novel therapeutic targets for heart disease. Michael Trembley By admin October 23, 2024 Michael Trembley, Ph.D. Trembley holds a Ph.D.

article thumbnail

F. William Studier receives the 2024 Merkin Prize in ceremony at the Broad Institute for developing technology used to produce millions of doses of COVID-19 vaccines

Broad Institute

William Studier receives the 2024 Merkin Prize in ceremony at the Broad Institute for developing technology used to produce millions of doses of COVID-19 vaccines The groundbreaking, scalable technology is widely used in laboratories around the world today to efficiently produce large amounts of protein and RNA. It’s changing the world.”

Vaccine 64
article thumbnail

Superhero Elena

KIF1A

Hundreds of doctor appointments and uncountable exams, second and third opinions, but nothing made sense. A few months before Elena turned 2 years old, we finally found a way to perform a genetic test with a German Laboratory. We felt we were getting into a tunnel that seemed to never end, and felt larger and larger every day.

Doctors 52
article thumbnail

A New Type of Bookworm: Bringing Patient Perspectives Into the Classroom?

KIF1A

A New Opportunity: the KIF1A Research Network in Action KIF1A.ORG was presented with such an opportunity by teaming up with Dr. Rebecca Shi of Stanford University, who worked to create a research laboratory course for undergraduates in the Stanford Biology department for the Spring 2023 semester. These are our future doctors.

Disease 98